메뉴 건너뛰기




Volumn 152, Issue 2, 2011, Pages 245-246

Aminoterminal natriuretic peptides and cardiovascular risk in an Italian male adult cohort

Author keywords

Cardiovascular prevention; Cardiovascular risk; Natriuretic peptides

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE;

EID: 80053574604     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2011.07.077     Document Type: Article
Times cited : (10)

References (7)
  • 1
    • 51549120537 scopus 로고    scopus 로고
    • State of the art: Using natriuretic peptide levels in clinical practice
    • A. Maisel, C. Mueller, and K. Adams Jr. State of the art: using natriuretic peptide levels in clinical practice Eur J Heart Fail 10 2008 824 839
    • (2008) Eur J Heart Fail , vol.10 , pp. 824-839
    • Maisel, A.1    Mueller, C.2    Adams Jr., K.3
  • 2
    • 73449123365 scopus 로고    scopus 로고
    • B-type natriuretic peptides and cardiovascular risk: Systematic review and meta-analysis of 40 prospective studies
    • E. Di Angelantonio, R. Chowdhury, and N. Sarwar B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies Circulation 120 2009 2177 2187
    • (2009) Circulation , vol.120 , pp. 2177-2187
    • Di Angelantonio, E.1    Chowdhury, R.2    Sarwar, N.3
  • 3
    • 42949162624 scopus 로고    scopus 로고
    • Plasma N-Terminal B-Type Natriuretic Peptide as an Indicator of Long-Term Survival After Acute Myocardial Infarction: Comparison With Plasma Midregional Pro-Atrial Natriuretic Peptide. The LAMP (Leicester Acute Myocardial Infarction Peptide) Study
    • DOI 10.1016/j.jacc.2008.01.041, PII S0735109708007158
    • S.Q. Khan, O. Dhillon, and D. Kelly Plasma N-terminal B-type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide J Am Coll Cardiol 51 2008 1857 1864 (Pubitemid 351615250)
    • (2008) Journal of the American College of Cardiology , vol.51 , Issue.19 , pp. 1857-1864
    • Khan, S.Q.1    Dhillon, O.2    Kelly, D.3    Squire, I.B.4    Struck, J.5    Quinn, P.6    Morgenthaler, N.G.7    Bergmann, A.8    Davies, J.E.9    Ng, L.L.10
  • 4
    • 80053571983 scopus 로고    scopus 로고
    • Natriuretic peptides and assessment of cardiovascular disease risk in asymptomatic persons
    • L.B. Daniels Natriuretic peptides and assessment of cardiovascular disease risk in asymptomatic persons Curr Cardio Risk Rep 4 2010 120 127
    • (2010) Curr Cardio Risk Rep , vol.4 , pp. 120-127
    • Daniels, L.B.1
  • 6
    • 46249090767 scopus 로고    scopus 로고
    • Natriuretic peptides: An update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases
    • DOI 10.1038/ajh.2008.174, PII AJH2008174
    • S. Rubattu, S. Sciarretta, V. Valenti, R. Stanzione, and M. Volpe Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases Am J Hypertens 21 2008 733 741 (Pubitemid 351913612)
    • (2008) American Journal of Hypertension , vol.21 , Issue.7 , pp. 733-741
    • Rubattu, S.1    Sciarretta, S.2    Valenti, V.3    Stanzione, R.4    Volpe, M.5
  • 7
    • 77952476534 scopus 로고    scopus 로고
    • What we have learned from risk charts?
    • E. Arslan, and S. Erdine What we have learned from risk charts? Future Cardiol 6 2010 285 287
    • (2010) Future Cardiol , vol.6 , pp. 285-287
    • Arslan, E.1    Erdine, S.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.